Changes and Significance of Serum Soluble Complement Receptor 2 in Patients with Primary Sjogren’s Syndrome
- 1 January 2014
- journal article
- Published by Hans Publishers in Immunology Studies
- Vol. 02 (02), 17-22
- https://doi.org/10.12677/is.2014.22004
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Topical and systemic medications for the treatment of primary Sjögren's syndromeNature Reviews Rheumatology, 2012
- Sjögren's syndromeThe Lancet, 2005
- A Critical Role for IL-21 in Regulating Immunoglobulin ProductionScience, 2002
- Complement activation in rheumatoid arthritis evaluated by C3dg and the terminal complement complexArthritis & Rheumatism, 1986